SAMe, Liver Toxicity Research Supported With $1.5 Mil. In Funding
This article was originally published in The Tan Sheet
Executive Summary
Three NIH bodies have issued an RFA providing $1.5 mil. in funding for research on SAMe's beneficial effects with regard to liver disease
You may also be interested in...
CAM Bioterrorism, HIV/AIDS Research To Be Funded By NCCAM
Basic and clinical research on the potential benefits of CAM therapies for HIV/AIDS will be sponsored in 2003 by the National Center for Complementary & Alternative Medicine
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands